Location
United Kingdom, Europe
Cheque size
$15M - $30M
Investment Stage
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
Medical Devices
About Investor
Genghis Lloyd-Harris is a Senior Advisor at Abingworth in London, deploying capital across biopharmaceuticals, clinical co-development, life-science tools and medical devices with an emphasis on exits via M&A and IPOs. He is based in London, England. He was previously a Managing Director in European Equity Research at Credit Suisse First Boston, trained as a paediatrician in Melbourne, and holds an MD from the University of Liverpool, a PhD in Clinical Pharmacology from the University of Melbourne and an MBA from Harvard Business School.
Previous investments
Nouscom
49M |2017
GenSight Biologics
36M |2015
42M |2013
Wilson Therapeutics
40M |2014
Similar Investors
TM
Tom Maughan
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,BJ
Bart de Jong
United Kingdom, Europe
$20M - $25M
Series A
,Series B
,CS
Christian Strain
France, Europe
$5M - $50M
Series B
,FL
Fabio Longo
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,RM
Rodolphe Menegaux
France, Europe
$1M - $20M
Seed
,Series A
,AB
Anas Biad
United Kingdom, Europe
$10M - $200M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.